Prevalence and Predictors of Sjögren’s Syndrome in Patients with Burning Mouth Symptoms

Aims: To investigate the prevalence and predictive factors of Sjögren’s syndrome (SS) in a cohort of patients with burning mouth symptoms. Methods: A total of 125 patients with burning mouth symptoms were enrolled in a prospective study and assessed for the presence of SS. The severity of oral symptoms was evaluated by using questionnaires. Salivary flow rates and salivary scintigraphy were used to evaluate salivary function. Patient laboratory work-ups were reviewed, and SS was diagnosed by a rheumatologist based on the American-European Consensus Group criteria. The differences between the SS patient group and the non-SS patient group were analyzed with chi-square test or t test. Results: A total of 12 of the 125 enrolled patients (9.5%) had a positive autoimmune antibody test, and 6 (4.8% of the entire cohort) had SS (4 [3.2%] primary and 2 [1.6%] secondary). Patients with SS exhibited significantly decreased hemoglobin levels, an increased erythrocyte sedimentation rate, and an increased prevalence of autoantibody positive results compared to non-SS patients. Salivary scintigraphy showed that the uptake ratio of the submandibular gland in SS patients was decreased significantly. Conclusion: The prevalence of SS in patients with burning mouth symptoms was 4.8%. Therefore, clinicians who treat patients with burning mouth symptoms should evaluate laboratory findings and salivary functions to identify patients with SS.

autoantibodies;burning mouth syndrome;salivary gland;Sjögren’s syndrome

1. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005;(1):CD002779.

2. Mock D, Chugh D. Burning mouth syndrome. Int J Oral Sci 2010;2:1–4.

3. Yilmaz Z, Renton T, Yiangou Y, et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007;14:864–871.

4. Rifkind JB. Burning mouth syndrome and “burning mouth syn- drome.” N Y State Dent J 2016;82:36–37.

5. Grushka M, Ching V, Epstein J. Burning mouth syndrome. Adv Otorhinolaryngol 2006;63:278–287.

6. Pinto A. Management of xerostomia and other complications of Sjögren’s syndrome. Oral Maxillofac Surg Clin North Am 2014;26:63–73.

7. Sun A, Wu KM, Wang YP, Lin HP, Chen HM, Chiang CP. Burning mouth syndrome: A review and update. J Oral Pathol Med 2013;42:649–655.

8. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: Overview and pa- tient management. Crit Rev Oral Biol Med 2003;14:275–291.

9. Soares MS, Chimenos-Küstner E, Subirá-Pifarrè C, Rodríguez de Rivera-Campillo ME, López-López J. Association of burn- ing mouth syndrome with xerostomia and medicines. Med Oral Patol Oral Cir Bucal 2005;10:301–308.

10. Lee YC, Hong IK, Na SY, Eun YG. Evaluation of salivary function in patients with burning mouth syndrome. Oral Dis 2015;21:308–313.

11. Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: Clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010;16:287–297.

12. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

13. Navazesh M, Kumar SK. Measuring salivary flow: Challenges and opportunities. JAm Dent Assoc 2008;139(suppl):s35–s40.

14. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: A revised version of the European cri- teria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–558.

15. Spadari F, Venesia P, Azzi L, et al. Low basal salivary flow and burning mouth syndrome: New evidence in this enigmatic pa- thology. J Oral Pathol Med 2015;44:229–233.

16. Al-Hashimi I, Khuder S, Haghighat N, Zipp M. Frequency and predictive value of the clinical manifestations in Sjögren’s syn- drome. J Oral Pathol Med 2001;30:1–6.

17. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Wolff A. Sjögren’s syndrome: The diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. J Oral Pathol Med 2005;34:1–6.

18. Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Primary Sjögren syndrome: Hematologic patterns of disease expres- sion. Medicine (Baltimore) 2002;81:281–292.

19. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma de- velopment in primary Sjögren syndrome: Clinical and patho- physiologic aspects. Medicine (Baltimore) 2009;88:284–293.

20. Zheng L, Yu C, Yang C, Xie L, Shi H, Wang Z. The serological profiles of subgroup of primary Sjögren’s syndrome correlation with the clinical features of parotid glands. J Craniomaxillofac Surg 2014;42:1260–1264.

21. Tensing EK, Nordström DC, Solovieva S, et al. Salivary gland scintigraphy in Sjögren’s syndrome and patients with sicca symptoms but without Sjögren’s syndrome: The psychologi- cal profiles and predictors for salivary gland dysfunction. Ann Rheum Dis 2003;62:964–968.

22. Vinagre F, Santos MJ, Prata A, da Silva JC, Santos AI. Assessment of salivary gland function in Sjögren’s syn- drome: The role of salivary gland scintigraphy. Autoimmun Rev 2009;8:672–676.

23. Chimenos-Kustner E, Marques-Soares MS. Burning mouth and saliva. Med Oral 2002;7:244–253.

24. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 1987;66(spec no):648–653.

25. Klasser GD, Balasubramaniam R, Epstein J. Topical review— connective tissue diseases: Orofacial manifestations including pain. J Orofac Pain 2007;21:171–184.